With experience, comes expertise. We happen to have both.
We’re deeply rooted in the scientific and market dynamics that drive the clinical decisions our clients make every day.
More than marketing experts in the complex field of oncology and hematology, we consider ourselves frontier-builders who can bridge the gap between clinical and commercial knowledge. With new discoveries rapidly emerging, our team is committed to communicating these advances in the most impactful ways possible.
We know the right channel mix for every insight and audience to advance your programs: live and virtual events, professional publications, in-depth clinical and market reports, digital platforms, and more.
A unique approach to strategic commercial success
Precise communication of the right insights to the right stakeholders through the right mix of channels
We created a robust, 3-phase process to help our clients navigate the scientific landscape, and to generate competitive solutions for your complex challenges. We call this D3 – Discover, Develop, Deliver – a unique approach that yields results, every time.
D3 is founded on our extensive experience with the pharma product development and commercialization process, including its key communication and stakeholder needs.
By understanding each specific phase of the product life cycle, we provide our partners with the end-to-end strategies and omnichannel tools they need to successfully reach an ever-evolving set of benchmarks and audiences.
With our proprietary D3 approach, we ensure that each client’s medical communications strategy reflects the ongoing product evolution, from inception to commercialization, and that every tactic precisely targets specific stakeholders with the right insights.
We know your business
With a strong vision and broad range of healthcare expertise, our team is committed to excellence
Ad Hoeks, MBA
“It’s great to work at an agency that provides the guiding force to help our clients achieve success, which ultimately benefits the patients.”
As president, Ad manages daily operations and guides the agency’s direction, growth, innovation, and product development.
Ad brings to TRM over 20 years of experience in the pharmaceutical industry. He joined TRM Oncology in 2012 from Merck & Co’s Global Marketing Department, where he was responsible for the inline oncology portfolio in Europe. Prior to that, Ad held several positions in (inter)national marketing and general management within Merck & Co.
Aviva Asnis Alibozek, PA C, DFAAPA
Executive VP Global Medical Affairs
“My work with TRM as both a leader in advancing oncology care and a key contributor to pharmaceutical medical strategy is rewarding on a daily basis.”
Aviva joined TRM Oncology in 2012. As EVP of Global Medical Affairs, she leads the execution of high quality and insightful medical communications deliverables.
Aviva is a board-certified physician assistant specializing in oncology, with 18 years of experience in clinical practice and the pharmaceutical industry. She has held cancer drug development and medical affairs leadership roles at Pharmacia, AstraZeneca, and IBA Molecular. Aviva is a Distinguished Fellow of the AAPA, a certified medical publications professional, and a clinical adjunct assistant professor at Quinnipiac University.
Senior VP, Global Strategic Business Development
“Together with our client partners, we are focused on improving patient care; that’s why I’m passionate about my job.”
Stefanie joined TRM in 2010. As the Senior VP of Global Strategic Business Development, Stefanie leads the global BD team in developing and maintaining client relationships as well as adding value as a strategic resource to our clients.
Stefanie brings 18+ years of oncology experience to the table. She joined TRM Oncology after over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor, where she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management.
Associate VP Global Account Services
“I’m proud to be part of a company that is so ambitious in advancing patient outcomes.”
Frank joined TRM Oncology in 2012. As Associate Vice President, Frank oversees and leads daily operations for the global account services team and manages standardization of operational procedures.
Frank started his career as an oncology nurse and worked for pharmaceutical companies (Janssen, Ortho-Biotech and Merck KGaA) for 12 years in sales, marketing, and leadership roles, and in these roles was deeply involved in the marketing and authorization of cancer compounds within the Netherlands.
Sandra Mendes, PhD, CMPP
Senior Director Publications
“I am proud to be part of a team of passionate scientific communicators with a firm commitment to deliver scientific and strategic excellence.”
Sandra joined TRM in 2011. As Senior Director of the Publications Department, Sandra leads a team of dedicated publication professionals in the execution of tailor-made solutions for our clients’ publication planning challenges.
Sandra is a certified medical publications professional with a PhD in biomedical sciences and over 10 years of experience in identifying communication needs for therapeutic products and devising strategies and tactics to fulfill those needs.
Kristof Petho, MD
Director Omnichannel Communication
“I am passionate about bringing meaningful innovation to our clients to ensure the best possible patient outcomes.”
Kristof joined TRM Oncology in 2012. As Director of Omnichannel Communication, he is responsible for the digital/omnichannel strategy to make sure the clients always have access to the latest innovations.
Kristof holds a medical degree and also brings 13+ years of pharmaceutical medical and marketing knowledge, with 10+ years in oncology. He held various marketing and leadership positions with Schering-Plough’s oncology unit in Hungary, then at Merck & Co after the merger.
Just some of our amazing clients
The world’s leading pharma and biotech companies trust us to help their innovations make a difference